Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction

Biochemical and Biophysical Research Communications

Volumn 439, Issue 1, 2013, Pages 142-147

  Misaka, Tomofumi ^a   Suzuki, Satoshi ^a   Miyata, Makiko ^a   Kobayashi, Atsushi ^a   Ishigami, Akihito ^b   Shishido, Tetsuro ^c   Saitoh, Shu ichi ^a   Kubota, Isao ^c   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Aging; Angiotensin II; Cardiac remodeling; Oxidative stress; Transgenic mouse

Indexed keywords

ANGIOTENSIN II; MYOSIN HEAVY CHAIN ALPHA; REGUCALCIN; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGING; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; GENE OVEREXPRESSION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; HYPERTENSION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

A; A′; AGING; ANGIOTENSIN II; ATRIAL MITRAL ANNULAR VELOCITY; BODY WEIGHT; BW; CARDIAC REMODELING; DHE; DIHYDROETHIDIUM; E; E′; EARLY DIASTOLIC MITRAL ANNULAR VELOCITY; FS; HEART WEIGHT; HW; INTRAVENTRICULAR SEPTAL THICKNESS; IVS; LEFT VENTRICULAR END-DIASTOLIC DIMENSION; LEFT VENTRICULAR END-SYSTOLIC DIMENSION; LEFT VENTRICULAR FRACTIONAL SHORTENING; LEFT VENTRICULAR WEIGHT; LVEDD; LVESD; LVW; OXIDATIVE STRESS; PEAK ATRIAL FILLING VELOCITY; PEAK EARLY DIASTOLIC LEFT VENTRICULAR FILLING VELOCITY; POSTERIOR WALL THICKNESS; PW; SA-Β-GAL; SENESCENCE MARKER PROTEIN 30; SENESCENCE-ASSOCIATED Β-GALACTOSIDASE; SMP30; TIBIAL LENGTH; TL; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PRESSURE; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CELL AGING; DIASTOLE; ECHOCARDIOGRAPHY; FIBROSIS; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; SUPEROXIDES;

MUS; MUS MUSCULUS;

EID: 84883821878     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.08.002     Document Type: Article

References (22)

1. Fujita T., Uchida K., Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim. Biophys. Acta 1992, 1116:122-128.
2. Fujita T., Mandel J.L., Shirasawa T., et al. Isolation of cdna clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome. Biochim. Biophys. Acta 1995, 1263:249-252.
3. Son T.G., Zou Y., Jung K.J., et al. SMP30 deficiency causes increased oxidative stress in brain. Mech. Ageing Dev. 2006, 127:451-457.
4. Sato T., Seyama K., Sato Y., et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am. J. Respir. Crit. Care Med. 2006, 174:530-537.
5. T. Misaka, S. Suzuki, M. Miyata, et al., Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodeling, Cardiovasc. Res. (2013) May 30 [Epub ahead of print].
6. Arimoto T., Takeishi Y., Takahashi H., et al. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice. Circulation 2006, 113:60-66.
7. Kitahara T., Takeishi Y., Harada M., et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc. Res. 2008, 80:40-46.
8. Kobayashi A., Ishikawa K., Matsumoto H., et al. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II-induced cardiac hypertrophy. Hypertension 2007, 50:1040-1048.
9. Tsao C.S., Leung P.Y., Young M. Effect of dietary ascorbic acid intake on tissue vitamin C in mice. J. Nutr. 1987, 117:291-297.
10. Du J., Liu J., Feng H.Z., et al. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2604-2613.
11. Wilson R.M., De Silva D.S., Sato K., et al. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. Hypertension 2009, 54:583-590.
12. Machii H., Saitoh S., Kaneshiro T., et al. Aging impairs myocardium-induced dilation in coronary arterioles: role of hydrogen peroxide and angiotensin. Mech. Ageing Dev. 2010, 131:710-717.
13. Dimri G.P., Lee X., Basile G., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9363-9367.
14. Jung K.J., Ishigami A., Maruyama N., et al. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp. Gerontol. 2004, 39:1169-1177.
15. Shimokawa N., Yamaguchi M. Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver. FEBS Lett. 1993, 327:251-255.
16. Son T.G., Kim S.J., Kim K., et al. Cytoprotective roles of senescence marker protein 30 against intracellular calcium elevation and oxidative stress. Arch. Pharm. Res. 2008, 31:872-877.
17. Little J.S., Broomfield C.A., Fox-Talbot M.K., et al. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem. Pharmacol. 1989, 38:23-29.
18. Kondo Y., Inai Y., Sato Y., et al. Senescence marker protein 30 functions as gluconolactonase in l-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5723-5728.
19. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346-354.
20. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
21. Wang M., Zhang J., Walker S.J., et al. Involvement of NADPH oxidase in age-associated cardiac remodeling. J. Mol. Cell. Cardiol. 2010, 48:765-772.
22. Ito N., Ohishi M., Yamamoto K., et al. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. Am. J. Hypertens. 2007, 20:792-799.